Objective: Smoking and overweight or obesity are preventable causes of disease and death. Women are reluctant to quit smoking because of concerns about postcessation weight gain, underscoring the need to elucidate patterns of weight concerns and associated psychosocial factors that may affect smoking cessation outcomes. The present study aimed to subtype women smokers based on psychosocial and behavioral factors associated with smoking and weight, and examine the utility of these subtypes to predict abstinence and postcessation weight gain. Method: Weight-concerned women (N ϭ 343) were randomized to 1 of 2 smoking cessation counseling adjuncts and 1 of 2 cessation medication conditions. At baseline, women were weighed and completed measures of depression, weight or appearance concerns, and eating behaviors. At 3-, 6-, and 12-months after the target quit date, women were weighed and completed self-report and biochemical smoking assessments. Results: Latent profile (LP) analyses supported a 3-profile model. The groups had typical (53%, LP1), minimal (33%, LP2), and high (14%, LP3) levels of depressive symptoms and weight concerns. At 12-months posttarget quit date, women in LP3 were more likely to relapse than women in LP1 (odds ratio, OR ϭ 2.93). Among abstinent women, those in LP2 and LP3 gained more postcessation weight than those in LP1. Conclusions: Heterogeneity in symptoms of depression, weight or appearance concerns, and eating behaviors was captured by three groups of women smokers, with unique risks for relapse and postcessation weight gain. The distinct profiles identified may help personalize the delivery of care for smoking cessation and, ultimately, reduce disease risk.
Cigarette smoking is the leading cause of preventable disease and death in the United States (U.S. Department of Health & Human Services, 2014) . Although average rates of smoking have declined over the past 50 years, the high prevalence of smokingrelated diseases among women smokers remains a serious public health concern (U.S. Department of Health & Human Services, 2014) . Smoking cessation interventions to address the unique needs of women smokers have specifically targeted women's concerns about postcessation weight gain and depressive symptoms (Torchalla et al., 2012) . Although interventions that address these factors demonstrate promising results in the short-term (i.e., 3 to 6 months), abstinence rates decrease significantly over longerterm (i.e., 12 month) follow-up (Torchalla et al., 2012) . Further tailoring of smoking cessation programs that accounts for individual differences in factors like weight concerns and mood that are common in women may enhance long-term cessation outcomes. Specifically, characterizing patterns of depressive symptoms, weight concerns, and associated psychosocial factors among women smokers may reveal subgroups of women who are at greater risk for relapse or postcessation weight gain.
Substantial prior research on women smokers has focused on mood and weight concerns as precipitants and maintaining factors for smoking (Pomerleau & Snedecor, 2008; Weinberger et al., 2017) and as targets of smoking cessation intervention (Levine et al., 2010; MacPherson et al., 2010) . At least half of women smokers express concerns about potential weight gain after quitting (Pirie, Murray, & Luepker, 1991; ), compared with one quarter of men smokers who endorse weight concerns (Clark et al., 2006) . Moreover, many women report that these concerns are a barrier to quitting smoking . In a national survey of women smokers in the United States, 39% of women reported that they would be "very concerned" about gaining weight if they stopped smoking cigarettes that day . Thus, postcessation weight concerns are common among women smokers and may hinder cessation efforts.
Smoking-related weight concerns are especially common among women smokers who engage in eating behaviors that may be maladaptive (Copeland & Carney, 2003) . Relatedly, maladaptive eating behaviors are common in women smokers (Kendzor, Adams, Stewart, Baillie, & Copeland, 2009 ) and the report of maladaptive eating behaviors affects smoking cessation outcomes. For example, women smokers with restrained eating patterns, who consciously control food intake, report gaining more weight and having shorter quit attempts compared with women smokers without restrained eating patterns (Jarry, Coambs, Polivy, & Herman, 1998) . Additionally, women smokers characterized as disinhibited eaters, who tend to consume food in response to emotional or environmental cues rather than physical cues (e.g., hunger), are also more likely to report greater postcessation weight gain (Hudmon, Gritz, Clayton, & Nisenbaum, 1999) . Thus, patterns of restrained or disinhibited eating may influence women's cessation and postcessation weight gain.
Maladaptive eating behaviors are frequently correlated with depressive symptoms (Spoor et al., 2006) , another important psychosocial factor related to women's cessation outcomes. Being a current smoker ) and a woman (Salk, Hyde, & Abramson, 2017) are both associated with increased odds of depression. Depressive symptoms are also a risk factor for poor cessation intervention outcomes. Women report heightened levels of depressed mood after quitting (Xu et al., 2008) , which has been shown to increase risk for relapse after cessation (Levine, Marcus, & Perkins, 2003; Weinberger et al., 2017) . Depressive symptoms have not been rigorously examined as a risk factor for postcessation weight gain, probably because few women with depression maintain abstinence. However, depression is associated with higher weight more generally (Luppino et al., 2010) and may influence postcessation weight gain. Thus, depression is common among women smokers, associated with weight, and a barrier to maintaining abstinence.
Weight concerns, maladaptive eating behaviors, and depression are interrelated and each has been associated with women's smoking; however, extant research has not simultaneously examined the utility of these behavioral and psychosocial factors in predicting smoking cessation outcomes. Consistent with personalized medicine approaches, we must better understand patterns of co-occurring symptoms to further tailor smoking cessation interventions for women and, ultimately, reduce disease risk. Therefore, we aimed to understand heterogeneity among women smokers by identifying subtypes of women characterized by different levels of depressive symptoms, weight and appearance concerns, and eating behaviors. We hypothesized that if unique subtypes were found, they would relate to abstinence and postcessation weight gain in the context of a smoking cessation randomized clinical trial.
Method Participants
Participants were weight-concerned women enrolled in a randomized, double-blind, placebo-controlled quit smoking trial investigating the efficacy of combining a cognitive-behavioral therapy for smoking-related weight concerns and bupropion (Levine et al., 2010) . Treatment-seeking women were recruited from the general population via posters, advertisements, and mailings. Of the 349 women enrolled in the parent trial, six were missing data on all five measures used to identify the subtypes of interest and, thus, were excluded from the current study. The 343 women included in the present analysis were between the ages of 18 and 65 years, smoked a minimum of 10 cigarettes per day, and endorsed concern about postcessation weight gain as assessed by the following two questions: (a) "How concerned are you about gaining weight after quitting?" and (b) "How concerned would you be if quitting smoking caused you to permanently gain 10 to 15 pounds, the amount typically gained by weight-concerned women after quitting?" . To be eligible, women were required to score Ն50 on a 1 (not at all) to 100 (extremely) scale on one of these questions. Only two women were excluded for not meeting the weight-concern criteria (Levine et al., 2010) .
Procedure
Interested women completed a telephone screening and eligible women were randomly assigned to receive either cognitivebehavioral therapy for smoking-related weight concerns or standard cessation treatment without a focus on weight. Women were further randomized to receive bupropion or placebo, resulting in a total of four intervention conditions: (a) weight concerns ϩ bupropion, (b) weight concerns ϩ placebo, (c) standard cessation counseling ϩ bupropion, and (d) standard cessation counseling ϩ placebo. There were no baseline differences in participant characteristics (e.g., age, body mass index [BMI] , and cigarettes per day) across the four intervention conditions (Levine et al., 2010) . All women were offered 12, 90-min group cessation counseling sessions focused on preparing to quit, the benefits of cessation, coping with smoking urges, and relapse prevention. The cognitive-behavioral therapy for weight concerns intervention included additional content related to weight concerns, such as education about cessation-related weight gain and instruction of cognitive strategies to identify and restructure maladaptive thoughts and beliefs. Study medication (bupropion or placebo) was initiated at the second treatment session and a target quit date 10 -14 days later was set. Women completed assessments before the first treatment session (baseline), and 1-, 3-, and 6-months after their target quit date. The trial was approved by the University of Pittsburgh Institutional Review Board, and women provided written informed consent. The study was conducted between September 1999 and October 2005. Details on the methods and results of the main trial have been previously reported (see Levine et al., 2010) .
Assessments
Demographic information. Women reported their age, education, and race/ethnicity at baseline. Women separately reported on their ethnicity (if they identified as Hispanic/Latina) and then described their race from the following categories: White, Black or African American, Asian, American Indian/Alaska Native, and Native Hawaiian or other Pacific Islander.
Depressive symptoms and lifetime Major Depressive Disorder. At baseline, women completed the Beck Depression Inventory (BDI; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961) , a reliable and valid 21-item self-report questionnaire of This document is copyrighted by the American Psychological Association or one of its allied publishers.
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depressive symptoms (Beck, Steer, & Carbin, 1988) . A metaanalysis estimated Cronbach's ␣ to be 0.81 for nonpsychiatric patients (Beck et al., 1988 (Mendelson et al., 2001) . Cronbach's ␣s were 0.91 and 0.89 in this sample. In the current study items were reverse-scored so that higher scores reflect greater weight and appearance concerns.
Eating behaviors. At baseline women completed the Three Factor Eating Questionnaire (TFEQ; Stunkard & Messick, 1985) , a reliable and valid self-report scale of eating behaviors. The Restraint and Disinhibition subscales were used in the current analyses because of their assessment of eating behavior. The Restraint subscale (21 items) measures conscious thoughts and behaviors related to restricting calorie intake. The Disinhibition subscale (16 items) reflects a general tendency to consume food in response to emotional or environmental cues rather than physical cues (e.g., hunger). The authors reported Cronbach's ␣s of 0.93 and 0.91 for Restraint and Disinhibition, respectively (Stunkard & Messick, 1985) . In the current sample, Cronbach's ␣s were 0.87 and 0.82, respectively.
Smoking history and behavior. Nicotine dependence was assessed at baseline using the Fagerström Test of Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991) . Continuous and dichotomous (high dependence Ն6) FTND scores were used to describe the subgroups of women. Women also self-reported the current number of cigarettes per day (CPD) and the number of previous quit attempts at baseline.
Smoking-specific weight concerns. Smoking-specific weight concerns were used to test for concurrent validity of the identified subgroups. We would expect that a group with high levels of weight and appearance concerns would also endorse high smoking-specific weight concerns. Women completed the Weight Concerns Scale and the Weight Efficacy After Quitting Scale (Borrelli & Mermelstein, 1998; Perkins et al., 2001 ) at baseline to assess smoking-specific weight concerns (6 items) and selfefficacy to manage weight after quitting (6 items). The authors reported Cronbach's ␣s of 0.87 and 0.88, respectively (Borrelli & Mermelstein, 1998) . In this sample, Cronbach's ␣s were 0.85 and 0.89, respectively. Women also completed the Weight-Control Smoking Scale at baseline to assess the extent to which individuals perceive smoking as a weight-control tool (Pomerleau et al., 1993 ). Cronbach's ␣ was 0.86 in both the original sample (Pomerleau et al., 1993) and the current sample.
Additionally, women answered three specific questions about postcessation weight gain at baseline: (a) "How concerned are you that quitting smoking will likely cause a total permanent weight gain of 10 to 15 pounds or more?"; (b) "How much would a 15-pound weight gain affect your motivation to quit smoking/stay free from smoking?"; and (c) "How much weight would you be willing to gain permanently if you quit smoking?" Women responded to the first two items on a 0 (not at all) to 100 (extremely) Likert rating scale.
Smoking point-prevalence. At 3-, 6-, and 12-months after the target quit date, women were interviewed about smoking using a timeline follow-back format (TLFB; Brown et al., 1998) and expired-air carbon monoxide (CO) was collected. Point-prevalence abstinence was defined as the self-report of no smoking during the 7 days before the assessment and a CO reading Յ8 ppm (Hughes et al., 2003; Benowitz et al., 2002) . In all cases where self-report or CO indicated smoking, women were coded as relapsed. Women who dropped-out of treatment were considered to have relapsed as of the day after the last visit on which abstinence was verified.
Weight outcome. Women were weighed in personal clothing without shoes before each assessment using a Seca 882 digital scale. Precessation weight was computed as the mean of weights at the three treatment sessions before the target quit date. Postcessation weight change was calculated as the difference between the precessation weight and weight at each assessment (3-, 6-, and 12-months) after the target quit date. Women were categorized as overweight (BMI 25.0 -29.9 kg/m 2 ) or obese (BMI Ն30 kg/m 2 ) at baseline.
Data-Analytic Plan
Analyses first examined whether a group-based analysis could meaningfully capture individual differences on baseline measures of depressive symptoms, weight and appearance concerns, restrained eating, and disinhibited eating. Latent profile analysis (LPA; Gibson, 1959; Lazarsfeld & Henry, 1968; Masyn, 2013) , a probabilistic technique that assumes that overall heterogeneity on continuous indicators results from the existence of two or more distinct latent classes of individuals, was used for this purpose. LPA was used in an exploratory manner because this was the first study to examine latent profiles of these constructs among weightconcerned women smokers. As such, no a priori hypotheses about the number of classes or homogenous subgroups were made.
The number of latent classes was examined iteratively, starting with the null hypothesis of only one latent class and specifying an increasing number of classes. Evaluation of the output for subsequent iterations included interpretability of the results, meaningfulness of the classes, relevant model fit statistics, and parsimony (Masyn, 2013) . Model fit was compared using the Bayesian Information Criterion (BIC), entropy (Celeux & Soromenho, 1996) , the adjusted Lo-Mendell-Rubin likelihood ratio test of model fit (adjusted LMR-LRT; Lo, Mendell, & Rubin, 2001) , and the bootstrapped likelihood ratio test (BLRT; McLachlan & Peel, 2000) . Models were estimated in Mplus using full information maximum likelihood for missing data (n ϭ 322 completed the BDI; n ϭ 343 This document is copyrighted by the American Psychological Association or one of its allied publishers.
completed all other measures) and maximum likelihood with robust SEs.
Chi-square and analysis of variance (ANOVA) were used to characterize the latent profiles further. Chi-square analyses were conducted with latent profile membership and the following dichotomous variables: education, race/ethnicity, and lifetime MDD diagnosis. ANOVAs were run with latent profile membership as the fixed factor and the following dependent variables: age, precessation weight, BMI, CPD, FTND, number of previous quit attempts, smoking cessation-specific weight concerns, selfefficacy to manage weight after quitting, weight control smoking, and the three questions about postcessation weight gain (see Method section). Post hoc testing with Bonferroni-adjustments was used to follow-up any significant effects. Analyses were run in SPSS/PASW.
Last, generalized mixed effect models were used to explore whether latent profile membership predicted relapse and postcessation weight gain at 3-, 6-and 12-months after the target quit date, beyond the effects of treatment condition. Based on the results of the latent profile analyses, n-1 theoretically meaningful contrasts were created to be included as predictors in the models. Time and interactions between time and each contrast variable were included as covariates. Treatment condition was represented as a covariate in all models by three variables: therapy group (cognitive-behavioral therapy for weight concerns vs. standard cessation treatment), medication group (bupropion vs. placebo), and the interaction of therapy group and medication group. Women receiving the combination of cognitive-behavioral therapy for smoking-related weight concerns and bupropion were the most likely to sustain abstinence at 6-months after the target quit date. There were no differences among abstinent women in postcessation weight gain across intervention conditions (see Levine et al., 2010 for more details).
Relapse analyses were evaluated on an intent-to-treat basis, regardless of medication adherence, treatment received, or nonattendance at follow-up visits. Analyses with postcessation weight gain were only conducted among those maintaining pointprevalent abstinence, given that the resumption of smoking confounds analyses of weight change. Mixed effect models were used to compare the LPA groups in postcessation weight gain, with fixed terms of the aforementioned group contrasts, time, the interaction of the contrasts and time, as well as precessation weight, and participant was included as a random term. Type I tests of fixed effects are reported for overall effects and contrasts were set to test profile differences at 3-, 6-, and 12-months after the target quit date. Both generalized mixed models and linear mixed models were run in SAS 9.4.
Results
See Table 1 for demographic information and smoking characteristics for the sample included in the current study (N ϭ 343). On average, the sample consisted of middle-aged, overweight, White Non-Hispanic women who completed some college or technical school, smoked roughly one pack of cigarettes a day, and had three previous quit attempts.
Latent Profile Analyses
Evaluation of the model statistics indicated that a three-class model provided the best fit to the data (see Table 2 ). The four-class model had the lowest BIC; however, the LMR-LRT comparison of the three-and four-class models was not significant, indicating that the four-class model did not fit the data better than the three-class model. The LMR-LRT comparison of the two-and three-class models was significant, indicating that the three-class model fit the data better than the two-class model. For the three-class model, average latent class probabilities for most likely class membership ranged from 88 to 92% and entropy was 0.77.
Latent Profile 1 (LP1; n ϭ 180; "Typically Concerned") endorsed average levels of depressive symptoms, weight and appearance concerns, disinhibition, and restraint for this sample of women. Latent Profile 2 (LP2; n ϭ 114; "Minimally Concerned") had low depressive symptoms, low weight and appearance concerns, and high disinhibition, relative to the other profiles. Latent Profile 3 (LP3; n ϭ 49; "Highly Concerned") had elevated depressive symptoms, high weight and appearance concerns, high restraint, and low disinhibition, relative to the other profiles (see Figure 1) .
Characterization of Latent Profiles
Demographic, weight, and smoking variables. The profiles did not differ on education, age, FTND score, or previous quit attempts (see Table 3 ). There was a significant relationship between latent profile membership and race/ethnicity, with the lowest proportion of racial-ethnic minority women in the Highly Concerned group (2%) compared with the Typically Concerned (13%) and Minimally Concerned (21%) groups. African American Non-Hispanic women represented most women in the racial/ethnic minority group. There were main effects of latent profile membership on BMI and CPD. Smoking-specific weight concerns. There were main effects of latent profile membership on the three measures and three individual items assessing smoking-specific weight concerns (see Table 3 ). Follow-up tests indicated that, compared with Typically Concerned women, Minimally Concerned women were less concerned that smoking would cause a permanent weight gain of 10 -15 pounds or more, reported their motivation to stay quit would be affected less by a 15-pound weight gain after quitting smoking, and reported they would be willing to gain more weight permanently if they quit smoking. Highly Concerned women did not differ significantly from Typically Concerned women on any of the smoking-specific weight concerns measures.
Latent Profile Membership Predicting Relapse and Postcessation Weight Gain
See Table 4 for abstinence rates and postcessation weight gain descriptive statistics for each latent profile as well as results from the mixed effects models. We created planned orthogonal contrasts with Typically Concerned women as the reference group. Results from mixed effects models indicated that Minimally Concerned women did not differ from Typically Concerned women in overall relapse rates. As compared with Typically Concerned women, Highly Concerned women were likely to relapse. More specifically, contrasts indicated that Highly Concerned women were more likely to relapse at 12-months after the target quit date, odds ratio (OR) ϭ 2.93, 95% confidence interval (CI) [1.07, 8.05], p ϭ .037, but did not differ at 3-or 6-months after the target quit date.
Overall, Minimally Concerned and Highly Concerned women did not differ from Typically Concerned women in postcessation weight gain. However, contrasts revealed that Minimally Concerned women had more postcessation weight gain at 12- This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
months after the target quit date than Typically Concerned women, at a marginal level of significance. This effect was not statistically significant at 3-or 6-months after the target quit date. Contrasts also indicated that Highly Concerned women had more postcessation weight gain than Typically Concerned women specifically at 12-months after the target quit date, at a marginal level of significance; this effect was not significant at 3-or 6-months after the target quit date.
Discussion
The present study was the first to characterize subtypes of weightconcerned women smokers, who comprise more than half of all women who smoke. Most women (53%; Typically Concerned; LP1) endorsed depression, eating, and weight-related symptoms that have been typically reported in previous samples of community women and weight-concerned women smokers (Beck et al., 1988; d Group differences were not examined to decrease family-wise error. Group differences were examined on the continuous measures of FTND and BMI. This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly. ). In contrast, one third of women (33%; Minimally Concerned; LP2) were distinguished by minimal mood, weight, and appearance concerns. A smaller subset (14%; Highly Concerned; LP3) was characterized by moderate depressive symptoms and high levels of weight and appearance concerns. The three groups also differed on BMI, race/ethnicity, cigarettes per day, lifetime MDD diagnosis, and smoking-specific weight concerns, as discussed further below. Moreover, group membership predicted relapse and postcessation weight gain, with women in the two less common groups (Minimally Concerned and Highly Concerned) demonstrating worse cessation-related outcomes at 12 months after the target quit date.
Highly Concerned Women Smokers, Latent Profile 3
The small group of women classified as Highly Concerned were, on average, women who had mild to moderate depressive symptoms (Beck et al., 1988) and levels of weight and appearance concerns similar to those reported by women with eating disorders (Keating, Tasca, & Hill, 2013) . Consistent with extant research on women smokers with high levels of weight concerns (Levine, Bush, Magnusson, Cheng, & Chen, 2013; , Highly Concerned women were mostly White Non-Hispanic, a large percentage had obesity, and most smoked more than one pack of cigarettes per day. Highly Concerned women also endorsed the highest level of restrained eating in this study; however, this level was comparable to restrained eating in other nonclinical samples of women (Hays & Roberts, 2008; Kruger, De Bray, Beck, Conlon, & Stonehouse, 2016; Provencher, Drapeau, Tremblay, Després, & Lemieux, 2003) .
The profile of moderate depressive symptoms and high weight concerns in the context of obesity and high numbers of cigarettes smoked per day suggests that this relatively small group of Highly Note. LP ϭ latent profile; OR ϭ odds ratio. a Only examined among women who were abstinent, of whom some did not provide weight information. Weight is presented in pounds. Treatment condition was included as a covariate in all models. Precessation weight was included as a covariate in postcessation weight gain models.
This document is copyrighted by the American Psychological Association or one of its allied publishers. This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Concerned women may be especially vulnerable to poor smoking cessation outcomes. Indeed, Highly Concerned women were almost three times more likely to relapse at 12-months after the target quit date compared with Typically Concerned women, with only 10% of Highly Concerned women maintaining abstinence at 12-months. Although the specific mechanisms contributing to these women's higher risk of relapse are unknown, their moderate depressive symptoms and elevated concern about postcessation weight gain may decrease their chances of successful smoking cessation. Moreover, at 12-months after the target quit date, the few Highly Concerned women who maintained abstinence gained an average of 15 pounds, more than two times the amount of postcessation weight gained by Typically Concerned women. This finding is consistent with research documenting that heavy smokers and smokers with obesity are at risk for greater than average postcessation weight gain (Veldheer, Yingst, Zhu, & Foulds, 2015) . Postcessation weight gain places Highly Concerned women at greater prospective risk for developing cardiometabolic diseases, such as Type 2 diabetes (Yeh, Duncan, Schmidt, Wang, & Brancati, 2010) ; however, maintaining abstinence can mitigate some of these health risks. Unfortunately, experiencing high rates of weight gain may be another reason for Highly Concerned women to resume smoking.
Notably, Highly Concerned women did not differ from Typically Concerned women on smoking-specific weight concerns or lifetime MDD, highlighting the utility of considering individual differences in current depressive symptoms and general weight concerns to elucidate subgroups of weight-concerned women smokers who are at greater than average risk for relapse and postcessation weight gain. Thus, women smokers with obesity, moderate depressive symptoms, and high levels of weight concerns are on a trajectory toward poor cessation outcomes and continued disease risk. Future research is needed to determine the optimal cessation intervention for a Highly Concerned woman. For example, more intensive treatment and possibly medication management could be advantageous in addressing the multiple cooccurring symptoms.
Minimally Concerned Women Smokers, Latent Profile 2
One out of three weight-concerned women smokers was characterized as Minimally Concerned. On average, Minimally Concerned women had normal weight, endorsed minimal depressive symptoms (Beck et al., 1988) , and the prevalence of lifetime MDD was lower than that expected among national samples of women (Kessler et al., 2010) . These women also had minimal levels of weight and appearance concerns, levels that were lower than those reported by community samples of women (Therrien et al., 2008) . Minimally Concerned women also reported the lowest levels of smoking-specific weight concerns among the overall group of weight-concerned women smokers. Surprisingly, Minimally Concerned women endorsed the highest levels of disinhibited eating compared with women in the other two groups, though disinhibited eating was not endorsed at clinically significant levels (Marcus, Wing, & Lamparski, 1985; Wadden, Foster, Letizia, & Wilk, 1993) . The implications of this finding are unclear. Disinhibited eating is usually positively related to weight, particularly in clinical samples (Bryant, King, & Blundell, 2008) . Some authors have suggested that disinhibition can be considered to reflect opportunistic eating or uncontrolled eating among women (Bryant et al., 2008; Yeomans, Leitch, & Mobini, 2008) . Thus, the disinhibited eating patterns endorsed by Minimally Concerned women may reflect that these women are simply less weightconcerned and engage in uncontrolled eating, which may have implications for postcessation weight gain.
Among women who maintained abstinence, Minimally Concerned women gained an average of 11 pounds at 12-months after the target quit date, more than 1.5 times the amount of postcessation weight gained by Typically Concerned women. Minimally Concerned women may have been susceptible to overeating after they quit smoking given their tendency toward disinhibited eating and their relatively low postcessation weight concerns. Thus, women smokers with normal weight and minimal depressive symptoms who are less weight-concerned are vulnerable to greater than average postcessation weight gain. It should be noted, however, that these Minimally Concerned women were not at greater risk for relapse compared with Typically Concerned women.
Future research is needed to determine the optimal cessation intervention for a Minimally Concerned woman. Most smoking interventions that target women focus on postcessation weight gain concerns and depressive symptoms, and women in the Minimally Concerned subgroup reported very few depressive symptoms despite being recruited for weight concerns. Therefore, Minimally Concerned women may benefit from a more standard behavioral smoking intervention that provides additional psychoeducation on postcessation weight gain and the associated health consequences.
Limitations and Future Directions
There are several limitations to the present study worth noting. First, the specificity of the sample limits the generalizability of the results. Although most women smokers are weight-concerned , one limitation of these findings is that they are specifically applicable to women who express postcessation weight concerns. Thus, the findings cannot be generalized to men smokers who have weight concerns. Future research is warranted to characterize men smokers based on unique psychosocial, behavioral, and/or other factors associated with smoking and weight gain for men. It also is important to conduct future studies that include a more representative sample with regard to race/ethnicity and take racial/ ethnic differences in postcessation weight gain concerns into account . Although the Highly Concerned women were more likely to be White Non-Hispanic, the current sample consisted predominantly of White Non-Hispanic women, limiting our understanding of the relationship between race/ethnicity and subtypes of women smokers. Research examining women who have attempted to quit more recently is also needed as the data for the current study were collected between 1999 and 2005 and data on changes in the amount, types, and characteristics of smokers have changed over time (Ng et al., 2014) . Last, information on weight gain was only available for women with point-prevalence abstinence. As such, the findings on weight gain may not be fully representative of the larger sample. To more comprehensively describe patterns This document is copyrighted by the American Psychological Association or one of its allied publishers.
of weight change in relation to smoking, future research should examine weight change among women who return to smoking and among women who maintain prolonged abstinence. The current findings highlight the utility of using brief, selfreport measures to elucidate patterns of depression, weight and appearance concerns, and eating behaviors among women smokers that are associated with cessation outcomes. In future investigations, it will be important to consider that the identified subtypes are unique to each sample. The number of subtypes and patterns of depressive symptoms, eating-, and weight-related concerns in each subtype may differ from those found in the current study and could, therefore, further inform distinct approaches to tailoring smoking cessation interventions for women.
Moreover, additional investigations with larger sample sizes are needed to examine the optimal smoking cessation treatment for a woman based on her profile of depressive symptoms, weight and appearance concerns, and eating behaviors. The current study was not powered to examine the relationship between subtype and treatment condition. For instance, we could not examine if, among the Highly Concerned women, those who received bupropion had better cessation outcomes than those who received the placebo. These studies are important to guide tailoring of smoking cessation interventions to fit the unique symptom profiles of women smokers.
Conclusions
Smoking and overweight or obesity are associated with significant disease risks. Women have great difficulty quitting smoking and gain postcessation weight that may impact their quit success. The current study identified subgroups of weightconcerned women smokers who were at greater than average risk for relapse and/or postcessation weight gain. The three distinct groups identified may help personalize the delivery of care for weight-concerned women smokers based on responses to short self-report questionnaires of depressive symptoms, weight and appearance concerns, and eating behaviors. In particular, these results highlight the significant disease risks for women smokers with obesity, high weight and appearance concerns, and moderate depressive symptoms, and call for focus on developing personalized adjunct interventions for this vulnerable group of women.
